ResearcherShanghai Jiao Tong UniversityNo recent work listed

Feng Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0003-2371-9579; OpenAlex author ID A5101760696. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

An Inflammatory Response Related Gene Signature Associated with Survival Outcome and Gemcitabine Response in Patients with Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3389/fphar.2021.778294 ↗
In vitro comparative studies of resveratrol and triacetylresveratrol on cell proliferation, apoptosis, and STAT3 and NFκB signaling in pancreatic cancer cells. Co-author DOI 10.1038/srep31672 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zhijun Xiao · 1 shared paper, 2021 · strength 0.14
- Paper An Inflammatory Response Related Gene Signature Associated with Survival Outcome and Gemcitabine Response in Patients w… DOI 10.3389/fphar.2021.778294 ↗
Xiang‐Lin Tan · 1 shared paper, 2016 · strength 0.06
- Paper In vitro comparative studies of resveratrol and triacetylresveratrol on cell proliferation, apoptosis, and STAT3 and NF… DOI 10.1038/srep31672 ↗
E Jian‐Yu · 1 shared paper, 2016 · strength 0.06
- Paper In vitro comparative studies of resveratrol and triacetylresveratrol on cell proliferation, apoptosis, and STAT3 and NF… DOI 10.1038/srep31672 ↗
Wen Yue · 1 shared paper, 2016 · strength 0.06
- Paper In vitro comparative studies of resveratrol and triacetylresveratrol on cell proliferation, apoptosis, and STAT3 and NF… DOI 10.1038/srep31672 ↗
JingJing Duan · 1 shared paper, 2016 · strength 0.06
- Paper In vitro comparative studies of resveratrol and triacetylresveratrol on cell proliferation, apoptosis, and STAT3 and NF… DOI 10.1038/srep31672 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.